Pancreatic Neoplasms: all 3,310 studies
Page 31 of 34. Open to participants first (910), then studies with results posted, then the rest; newest registration first within each.
- S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based RegimenTerminatedNCT00602745Phase 3
- Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic CancerCompletedNCT00602602Phase 2
- Cetuximab and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by SurgeryCompletedNCT00599833Phase 2
- Safety and Efficacy Study of 90Y-hPAM4 at Different DosesCompletedNCT00597129Phase 1/2
- Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic CancerTerminatedNCT00593008Phase 1
- Pancreatic and Gastrointestinal Tumor Registry and Tissue CollectionCompletedNCT00584363
- A Prospective Study of EUS Guided Celiac BlockCompletedNCT00583271
- Depression, Cytokines and Pancreatic CancerCompletedNCT00582699
- Collection of Tissue & Blood From Patients w/ Benign & Malignant Tumors of the Soft Tissue & Gastrointestinal TractActive, not recruitingNCT00582647
- Detection of Peritoneal Micrometastasis in Gastric and Pancreatic Cancer in Peritoneal Wash SamplesCompletedNCT00582062
- Clinical Outcomes in Hereditary CancerWithdrawnNCT00580021
- Vaccine Study for Surgically Resected Pancreatic CancerCompletedNCT00569387Phase 2
- Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic CancerCompletedNCT00568646Phase 2
- Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic CancerCompletedNCT00565487Phase 1
- Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin, in Pancreatic CancerTerminatedNCT00564720Phase 2
- Nimotuzumab in Adults With Pancreatic CancerCompletedNCT00561990Phase 2/3
- Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract CancerCompletedNCT00559598
- A Randomized Phase 2 Study of ARQ 197 Versus Gemcitabine in Treatment-Naïve Patients With Unresectable Locally Advanced or Metastatic Pancreatic AdenocarcinomaCompletedNCT00558207Phase 2
- A Phase 1 Study Testing CP-675,206 In Combination With Gemcitabine In Patients With Previously Untreated, Advanced Pancreatic CancerCompletedNCT00556023Phase 1
- A Phase II Trial of TPI 287 in Patients Advanced, Unresectable Pancreatic CancerTerminatedNCT00553813Phase 2
- Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver CancerStatus unknownNCT00553683Phase 1/2
- Expression of Inflammatory Proteins in Pancreatic CancerStatus unknownNCT00551057
- Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic CancerCompletedNCT00548626Not applicable
- Positron Emission Tomography Using [18F]-Labeled Substance P Antagonist Receptor Quantifier in Finding Disease in Patients With Pancreatic CancerCompletedNCT00547612Phase 1
- Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic CancerCompletedNCT00547144Phase 1
- Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal CancerCompletedNCT00544193Phase 1
- Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerStatus unknownNCT00541021Phase 3
- A Study of Gemcitabine ± Erlotinib and DN-101 Versus Gemcitabine ± Erlotinib and Placebo in Patients With Advanced Pancreatic CancerSuspendedNCT00536770Phase 2
- Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic CancerCompletedNCT00536614Phase 2
- Study With Gemcitabine and RTA 402 for Patients With Unresectable Pancreatic CancerTerminatedNCT00529113Phase 1
- Pancreatic Cancer Genetic Epidemiology (PACGENE) StudyActive, not recruitingNCT00526578
- Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By SurgeryWithdrawnNCT00524069Not applicable
- Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic CancerCompletedNCT00515866Phase 1
- GEM vs GEM+TS-1 for Advanced Pancreatic CancerCompletedNCT00514163Phase 2
- Safety/Efficacy Study of Rexin-G to Treat Pancreatic CancerCompletedNCT00504998Phase 1/2
- Preoperative Stent StudyCompletedNCT00501176Not applicable
- Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic TailCompletedNCT00500968Not applicable
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00499265Phase 2
- Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic CancerCompletedNCT00498225Phase 3
- Phase II Trial of Erlotinib in Advanced Pancreatic CancerCompletedNCT00497224Phase 2
- Perioperative Cancer Cell Dissemination and Systemic Immune Suppression in Resectable Ductal Pancreatic AdenocarcinomaCompletedNCT00495924
- AVN944 in Combination With Gemcitabine for the Treatment of Pancreatic CancerTerminatedNCT00493441Phase 2
- Trial of Pemetrexed for Patients With Pancreatic Cancer Which Cannot be Treated With Surgery or is MetastaticCompletedNCT00490373Phase 2
- Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic PancreatitisCompletedNCT00489671
- Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or GallbladderCompletedNCT00489515
- Comparing Endoscopic Based Stent Strategy Versus Bypass Surgery in Non-resectable Periampullary CancerWithdrawnNCT00487851Phase 2
- Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic CancerStatus unknownNCT00486460Phase 3
- A Phase I Trial of Capecitabine in Combination With Gemcitabine and Erlotinib for Advanced Pancreatic CancerCompletedNCT00480584Phase 1
- Making Decisions About Participating in a Cancer Clinical Trial for Patients With Stage II, Stage III, or Stage IV Pancreatic Cancer or Stage III or Stage IV Colon Cancer or Rectal CancerCompletedNCT00478010Not applicable
- Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid TumoursCompletedNCT00475956Phase 1
- PhI Study of Erbitux & Gemcitabine w/Radiation Therapy for Locally Adv. Pancreas CaCompletedNCT00467116Phase 1
- Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00462852Phase 2
- Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid TumorsCompletedNCT00462553Phase 1
- Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic CancerCompletedNCT00460174Phase 2
- Cetuximab, Gemcitabine, and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00448838Not applicable
- Capecitabine/Erlotinib Followed of Gemcitabine Versus Gemcitabine/Erlotinib Followed of CapecitabineStatus unknownNCT00440167Phase 3
- Cancer of the Pancreas Screening Study (CAPS 3)CompletedNCT00438906
- A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic CancerCompletedNCT00436423Phase 2
- Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic CancerCompletedNCT00436410Early Phase 1
- Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By SurgeryStatus unknownNCT00436267Phase 2
- Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid TumorsCompletedNCT00433602
- Stereotactic Radiation Therapy and Combination Chemotherapy in Treating Patients Undergoing Surgery for Locally Advanced Pancreatic CancerCompletedNCT00425841Phase 2
- Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00425360Phase 3
- Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.CompletedNCT00423254Phase 1
- Proteomic Analysis of HLA Complex in Solid Cancers: Breast, Ovary, Colon, Rectum, Stomach, and PancreasStatus unknownNCT00419627
- Outcome of Pancreatic Stump Closure Following Resection of Tumors of the Head of the Pancreas.Status unknownNCT00419614
- Phase II Study of PX-12 in Patients With Advanced Pancreatic CancerTerminatedNCT00417287Phase 2
- Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing RegimenCompletedNCT00417209Phase 3
- Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00416507Phase 3
- Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic AdenocarcinomaTerminatedNCT00415454Phase 1
- An Imaging Study of [18]F-fluoro-3'-Deoxy-3'-L-fluorothymidine ([18]F-FLT) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Who Will be Treated With Gemcitabine or Other Nucleoside AnalogsTerminatedNCT00414570Early Phase 1
- Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By SurgeryTerminatedNCT00410774Phase 1/2
- A Study of Volociximab in Combination With Gemcitabine in Metastatic Pancreatic CancerCompletedNCT00401570Phase 2
- Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With GemcitabineCompletedNCT00397787Phase 2
- Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerCompletedNCT00397384Phase 1
- Safety and Efficacy Therapy of Gemcitabine and Erbitux® to R0 or R1 Resected Pancreatic CancerCompletedNCT00395252Phase 2
- Chemoradiation-Induced Nausea and Emesis: Quality of LifeTerminatedNCT00394602
- Study of Mitomycin-C in Patients With Advanced or Recurrent Pancreatic Cancer With Mutated BRCA2 GeneWithdrawnNCT00386399Phase 2
- Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid TumorsCompletedNCT00385177Phase 1
- EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the PancreasCompletedNCT00377936Phase 2
- Zinc Supplements in Lowering Cadmium Levels in SmokersCompletedNCT00376987Phase 2
- Phase I Study of Gemcitabine, Sorafenib and Radiotherapy in Patients With Unresectable Pancreatic CancerCompletedNCT00375310Phase 1
- AZD6244 vs. Capecitabine (Xeloda®) in Patients With Advanced or Metastatic Pancreatic Cancer, Who Have Failed First Line Gemcitabine TherapyCompletedNCT00372944Phase 2
- Changes in Muscle Tissue in Patients With Pancreatic CancerCompletedNCT00369460
- Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid TumorsCompletedNCT00369109
- Safety Study to Determine the Appropriate Dose of Antibody Against Tumor Cells to Best Target Patients With Pancreatic Cancer.TerminatedNCT00364364Early Phase 1
- A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing PancreaticoduodenectomyTerminatedNCT00359320Not applicable
- GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic CancerTerminatedNCT00358566Phase 3
- Maytansinoid DM4-Conjugated Humanized Monoclonal Antibody huC242 in Treating Patients With Solid TumorsCompletedNCT00352131Phase 1
- 32P BioSiliconTM in Addition to Gemcitabine in Pancreatic CancerStatus unknownNCT00346281Phase 2
- Preop Chemoradiation Resectable PancreasCompletedNCT00336648Phase 2
- Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By SurgeryCompletedNCT00335543Phase 2
- A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung CancerCompletedNCT00325494Phase 1
- TMS for the Treatment of Pancreatic Cancer PainCompletedNCT00324428Not applicable
- Weekly Dosing of an Integrative Chemotherapy Combination to Treat Advanced Pancreatic CancerStatus unknownNCT00323583Phase 2
- Gemcitabine and Capecitabine in Patients With Advanced Pancreatic CancerCompletedNCT00316420Phase 1
- Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During PregnancyCompletedNCT00310115
- Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic CancerTerminatedNCT00307723Phase 1/2
- Capecitabine as Second-Line Therapy in Treating Patients With Stage IV Pancreatic Cancer Who Have the Thymidylate Synthase GeneCompletedNCT00303927Phase 2